Serum MMP-9 levels were significantly upregulated in breast cancer patients compared to normal controls and high serum MMP-9 levels were significantly associated with poor prognostic factors, such as higher tumor size and lymph node metastasis, and lower relapse-free survival and OS rates (51). Here, MMP9 is linked to metastatic malignant neoplasm in the lymph nodes.